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An increased expression of the ischemia-responsive protein gene (irp94) was detected in
a Mongolian gerbil brain after an ischemic injury, particularly in the cerebral cortex and
hippocampus. In a rat phaeochromocytoma tumour cell line (PC12 cells), actinomycin D
blocked the irp94 gene expression but cycloheximide did not. This indicates that irp94 gene
expression is transcriptionally controlled. The half-life of irp94 mRNA was estimated to be
approx. 5 h using 5,6-dichloro-1--d-ribofuranosylbenzimidazole (DRB). In addition, irp94
expression was enhanced by either endoplasmic reticulum (ER)-stress-inducible drugs or
protease inhibitors. This suggests that irp94 gene expression is strongly associated with the
unfolded protein response (UPR) in neurons.
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Introduction
The cDNA that encodes a 94 kDa ischemia-re-
sponsive protein (irp94) from the rat hippocampal
was isolated using a mRNA differential display
technique in the four-vessel occlusion model in
rats. The Yagita group characterized irp94 at the
molecular level (Yagita et al., 1999). Sequence
analysis showed that rat irp94 shared a high ho-
mology with mouse apg-2 ( 90%), human heat
shock protein (hsp) 70RY and a member of the
HSP110 family (approx. 60%). The irp94 mRNA
was constitutively expressed in the normal hippo-
campus. However, its expression is mainly en-
hanced under ischemic injury for 10 min (1.9-fold
increase) and 15 min (3.4-fold increase) but not by
heat shock. This suggests that irp94 expression was
enhanced and not associated with the heat shock
signaling mechanism (Yagita et al., 1999). Irp94,
a novel member of the HSP110 family, plays an
important role in altering neuronal functions. In
addition, the localization of irp94 mRNA was de-
termined in the endoplasmic reticulum using in
situ hybridization histochemistry (Yagita et al.,
2001).
It was also suggested that irp94, like a molecular
chaperone, plays a role in protecting the cell
against external stimulation, particularly after
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transient forebrain ischemia in a rat (Koh et al.,
2000). On the other hand, in a thyroid cell culture
model, FRTL-5, the irp94 expression pattern was
similar to that of the endoplasmic reticulum chap-
erone, Erp72, but not to the cytosol chaperone,
hsp72. The functional role of irp94 was suggested
to be a component of the stress response in neu-
rons. In addition, its enhanced expression was de-
tected when the cells were incubated with the thy-
roid-stimulating hormone (Kim et al., 2001). This
study demonstrates the molecular properties of
irp94 expression such as the mRNA half-life, re-
sponse to ER (endoplasmic reticulum) stresses
and transcriptional control. As a step toward eluci-
dating the function of the irp94 in neurons, it is
essential to know how the irp94 gene is controlled
under different conditions.
Materials and Methods
Male Mongolian gerbils (Meriones unguiculatus;
60Ð80 g) were anesthetized with halothane (1.5%
in 70% N2O and 30% O2) and given an ischemic
injury. Both the common carotid arteries (CCAs)
were exposed by a ventral midline incision and
separated carefully from the adjacent veins and
nerves. After scarification, the brain tissues were
removed as quickly as possible under standard
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conditions. The total RNA was isolated and exam-
ined by Northern blot analysis (Giuffrida et al.,
1992).
Rat phaeochromocytoma PC12 cells were rou-
tinely cultured in Dulbecco’s Modified Eagle Me-
dia (DMEM) supplemented with 10% horse se-
rum and 5% fetal calf serum on collagen-coated
dishes in a humidified 5% CO2 atmosphere at
37 ∞C (De Leon et al., 1994). The total RNA was
extracted using a SV Total RNA isolation system
(Promega, Medison, USA). Each 10 μl aliquot of
the total RNA was separated on denaturing aga-
rose gel (2.5% agarose containing 2.2 m formalde-
hyde), transferred onto a nylon blotting mem-
brane (Schleicher & Schuell, New Hampshire,
USA), and the resulting membrane was hybrid-
ized with a high concentration SDS buffer [7%
SDS, 50% formamide, 5 ¥ SSC (43.8 g NaCl, 22 g
sodium citrate/l water), 2% blocking reagent, and
50 mm sodium phosphate] at 50 ∞C overnight and
with the [α-32P]dCTP-labelled irp94 DNA probe
(501 bp), which was acquired by RT-PCR using
the forward primer (5-CAGGATTTGCCCTAT-
CCAGA-3) and reverse primer (3-GTCATTC-
CGTTCCTTCTCCA-5) derived from rat irp94
(GenBank accession No. AF077354). Both RT-
PCR primers were supplied by Bioneer Co., Ko-
rea. The membrane was rinsed twice with 2 ¥ SSC
and 0.1% SDS, and exposed to a X-ray film at
Ð70 ∞C for 5Ð24 h. The ER-stress-inducible drugs
tunicamycin, A23187 and DTT, the proteasome
inhibitors ALLN (N-acetyl-l-leucinyl-l-leucinyl-
norleucinal) and MG 132 (carbobenzoxy-l-leucyl-
l-leucyl-l-leucinal), unless otherwise noted, were
purchased from Sigma (St. Louis, USA).
Results and Discussion
Northern blot analysis of irp94 mRNA in Mon-
golian gerbil brain, where only common carotid
arteries (CCAs) exist without a vertebral artery,
was carried out to determine the expression level
of the irp94 gene induced by the CCAs. After in-
ducing an occlusion for 30 min followed by reper-
fusion for 3 h, the brain was dissected into the ce-
rebral cortex, cerebellum, hippocampus, and
spinal cord. The total RNA was isolated and 20 μg
of each sample were used as described in Materi-
als and Methods. Strong irp94 mRNA expression
was observed at both the cerebral cortex (approx.
3.5 times) and hippocampus (approx. 4 times
higher) in the experimental group but not in the
Fig. 1. Northern blot analysis of irp94 mRNA in Mongo-
lian gerbil brain. The upper panel in the Northern blot
shows irp94 mRNA resulting from ischemia (T), the
middle panel shows the expression without the induction
of ischemia (UT), and the left lower panel shows rat 18S
rRNA as a loading control. The irp94 band intensities
were measured using the ImageQuant software package.
The experiments were performed in duplicate and the
average result is indicated in the bar graph. 18S (18S
rRNA) was used to indicate the equivalence of the load
on the gel. Northern blotting conditions are described in
Materials and Methods.
control group (Fig. 1). It was already reported that
the induction of GRP94 gene expression by the
CCAs is mainly detected at the occipital lobe (Kim
et al., 2003). However, in this case, irp94 was ex-
pressed differently at the cerebral cortex and hip-
pocampus.
PC12 cells were treated with actinomycin D
(AD; transcription inhibitor) and cycloheximide
(CH; translation inhibitor) for the indicated times
in order to determine if irp94 mRNA expression
is regulated at the transcriptional or translational
steps, respectively (Park et al., 2001). Fig. 2 shows
the Northern blotting results. When the cells were
treated with 0.2 μg/ml AD for 2 h and 0.2 μg/ml
AD for 10 h, the resulting signal of irp94 mRNA
almost vanished. On the other hand, for the cells
treated with 0.2 μg/ml CH (2 h), the expression
pattern was similar to that of the control, even
though its expression was slightly weaker. A com-
paratively weaker irp94 mRNA expression was
observed in the cells treated with 2 μg/ml CH for
10 h comparing its expression with the control
group. This was attributed to a side effect of the
depressed degree of translation. It is suggested
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Fig. 2. Effects of actinomycin D (AD) and cycloheximide (CH) on irp94 mRNA. Confluent PC12 cells were treated
with either actinomycin D or cycloheximide for the indicated times and doses, respectively. C, control; lane 1, 0.2 μg/ml
AD for 2 h; lane 2, 0.2 μg/ml AD for 10 h; lane 3, 2 μg/ml CH for 2 h; lane 4, 2 μg/ml CH for 10 h; T, ischemia
induction. Each lane equivalent total RNA was used in Northern blotting and the irp94 band intensities were
measured using the ImageQuant software package. All experiments were carried out in duplicate and the average
result is indicated in the bar graph.
that irp94 gene expression in the neurons would
be controlled in the transcription step not in the
translation step.
The half-life of irp94 mRNA in a neuron was
estimated using DRB (5,6-dichloro-1--d-ribofu-
ranosylbenzimidazole), which is a specific inhibi-
tor of RNA polymerase II (Sinn and Sigmund,
1999). DRB treatment prevents new mRNA syn-
thesis and allows to monitor intracellular residue
mRNAs. As shown in Fig. 3, the expression level
of irp94 mRNA in the neurons gradually weak-
ened with time, the basal signal being detected
after 6 h. This means that the previously aggra-
vated irp94 mRNA had almost decayed. Finally,
the half-life of irp94 mRNA in the neurons was
estimated to be approx. 5 h, when half of the irp94
mRNA in the neurons had been destroyed.
As shown in Fig. 4, the PC12 cells were treated
with some types of ER-stress-inducible drugs such
as the calcium ionophore A23187, BFA (brefeldin
A), tunicamycin, DTT (dithiothreitol) and H2O2.
Of these, the maximal response of irp94 mRNA
expression against the ER-stress-inducible drugs
was observed with tunicamycin, which inhibited
N-glycosylation on the newly synthesized secre-
tory and membrane protein in the ER. None of
the other drugs, except for H2O2, produced any
significant induction of irp94 mRNA. This shows
that irp94 gene expression is ER-stress-inducible.
In particular, the expression is susceptible to tuni-
camycin. It means unfolded/misfolded proteins
causing a deficiency in N-glycosylation are main
Fig. 3. Estimation of the irp94 mRNA level in a cell using
5,6-dichloro-1--d-ribofuranosylbenzimidazole (DRB).
Confluent PC12 cells were treated with DRB (25 μg/ml)
for the indicated times. C, control; lane 1, after 2 h; lane
2, after 4 h; lane 3, after 6 h; lane 4, after 8 h. The total
RNA was isolated at various times after washing out the
old medium. Each lane equivalent total RNA was used
in Northern blotting and the irp94 band intensities were
measured using the ImageQuant software package. All
experiments were carried out in duplicate and the aver-
age result is indicated in the bar graph.
triggers of irp94 mRNA for the post-translational
modification of the secretory glycoproteins com-
pared with other ER stresses (Park et al., 2005).
According to the up-dated study when inducing
ER stress, the concept of endoplasmic reticulum-
associated degradation (ERAD) has been used to
show that the abnormal protein integrated in ER
is broken down at a steady rate (Meusser et al.,
2005). Proteins destined for degradation in the ER
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Fig. 4. The expression of irp94 against ER-stress-inducible drugs. Confluent PC12 cells were treated with ER-induci-
ble drugs for 3 h. C, control; lane 1, 10 μm Ca2+ ionophor A23187; lane 2, 10 μg/ml BFA; lane 3, 20 μg/ml tunicamycin;
lane 4, 3 mm DTT; lane 5, 10 mm H2O2. Each lane equivalent total RNA was used in Northern blotting and the
irp94 band intensities were measured using the ImageQuant software package. All experiments were carried out in
duplicate and the average result is indicated in the bar graph.
Fig. 5. The expression of irp94 against the proteasome inhibitors. Confluent PC12 cells were treated with the protea-
some inhibitors for 2 h. C, control; lane 1, 25 μm ALLN; lane 2, 25 μm MG 132. Each lane equivalent total RNA
was used in Northern blotting and the irp94 band intensities were measured using the ImageQuant software package.
All experiments were carried out in duplicate and the average result is indicated in the bar graph.
lumen must be transported across the ER mem-
brane to the cytosol, where they can be degraded
through the assistance of the 26S proteasome. It
was already reported that the inhibition of the 26S
proteasome enhances the expression of the ER-
resident chaperone, which is in this case ERSD
(ER storage disease) (Kim and Arvan, 1998). This
study examined whether or not irp94 expression is
inducible when the cells are treated with protea-
some inhibitors. Strong irp94 expression was de-
tected after each ALLN and MG 132 treatment
(Fig. 5). This shows that the expression pattern of
irp94 is similar to the typical ER-stress-inducible
chaperones. This suggests that irp94 may act
through a process that directly removes the pro-
tein from the folding environment of the ER.
In summary, a significant increase in the ische-
mia-responsive protein (irp94) gene expression
was detected in both cerebral cortex and hippo-
campus in an in vivo Mongolian gerbil brain is-
chemic injury model. In PC12 cells, irp94 gene ex-
pression was transcriptionally controlled because
actinomycin D (transcription inhibitor) blocked
the irp94 expression while cycloheximide (transla-
tion inhibitor) did not. The half-life of irp94
mRNA was estimated to be approx. 5 h by DRB.
In addition, the expression of irp94 was enhanced
by either ER-stress-inducible drugs such as cal-
cium ionophore A23187, BFA (brefeldin A), tuni-
camycin, DTT and H2O2, and protease inhibitors
like ALLN and MG 132. These results have poten-
tial implications in brain ischemia. This is because
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irp94 expression is strongly associated with the un-
folded protein response (UPR), which is con-
served in all eukaryotic cells and participates in the
progression of brain ischemia. Future studies, re-
lating irp94 activation to brain ischemia protec-
tion, as well as studies examining the roles of other
branches of the UPR during ischemia damages,
will be needed to further illuminate the potential
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